Page last updated: 2024-09-03

mk 0663 and Weight Gain

mk 0663 has been researched along with Weight Gain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Akter, KA; Alam, MA; Kabir, F; Khan, F; Lasker, S; Mamun, F; Nahar, K; Rahman, MM; Subhan, N; Yasmin, T	1

Other Studies

1 other study(ies) available for mk 0663 and Weight Gain

Article	Year
Etoricoxib treatment prevented body weight gain and ameliorated oxidative stress in the liver of high-fat diet-fed rats. Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:1 Topics: Animals; Antioxidants; Catalase; Cyclooxygenase 2 Inhibitors; Diet, High-Fat; Etoricoxib; Glutathione; Liver; Male; Malondialdehyde; Metabolic Syndrome; Oxidative Stress; Peroxidase; Rats, Wistar; Superoxide Dismutase; Weight Gain	2021

Article

Year

Etoricoxib treatment prevented body weight gain and ameliorated oxidative stress in the liver of high-fat diet-fed rats.

Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:1

Topics: Animals; Antioxidants; Catalase; Cyclooxygenase 2 Inhibitors; Diet, High-Fat; Etoricoxib; Glutathione; Liver; Male; Malondialdehyde; Metabolic Syndrome; Oxidative Stress; Peroxidase; Rats, Wistar; Superoxide Dismutase; Weight Gain

2021